EP 1303528 A1 20030423 - ADENOSINE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
Title (en)
ADENOSINE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
Title (de)
ADENOSIN-VERBINDUNG UND DIESE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSTELLUNG
Title (fr)
COMPOSE D'ADENOSINE ET COMPOSITIONS PHARMACEUTIQUES CONTENANT CE COMPOSE
Publication
Application
Priority
EP 0006958 W 20000712
Abstract (en)
[origin: WO0204474A1] An adenosine compound having the formula (I) wherein R represents a straight or branched lower alkyl group and R<1> represents a C2 to C6 lower alkylamino group or a substituent having the formula (II), (III) or (IV) wherein R<2> independently represent a hydrogen group or lower alkyl group, X represnts N-R<3>, O or CH2, R<3> represents a hydrogen atom, lower alkyl group or benzyl group and n represents an integer of 1 to 6, or a pharmaceutically acceptable salt thereof or a hydrate thereof, and a pharmaceutical composition containing the same. This compound have an anti-hyperlipemia, antiallergic, antidiabetes or analgesic action.
IPC 1-7
IPC 8 full level
C07H 19/167 (2006.01); A61K 31/7076 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 9/06 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 13/12 (2006.01); A61P 25/00 (2006.01); A61P 25/08 (2006.01); A61P 29/00 (2006.01); C07H 19/16 (2006.01)
CPC (source: EP)
A61P 3/04 (2017.12); A61P 3/06 (2017.12); A61P 3/10 (2017.12); A61P 9/06 (2017.12); A61P 9/10 (2017.12); A61P 9/12 (2017.12); A61P 13/12 (2017.12); A61P 25/00 (2017.12); A61P 25/08 (2017.12); A61P 29/00 (2017.12); C07H 19/16 (2013.01)
Citation (search report)
See references of WO 0204474A1
Designated contracting state (EPC)
DE ES FR GB IT
DOCDB simple family (publication)
WO 0204474 A1 20020117; CA 2416199 A1 20020117; EP 1303528 A1 20030423; JP 2004502780 A 20040129
DOCDB simple family (application)
EP 0006958 W 20000712; CA 2416199 A 20000712; EP 00945940 A 20000712; JP 2002509337 A 20000712